DK0533264T3 - Hidtil ukendt fremgangsmåde til fremstilling af anti-ulcus-midler - Google Patents

Hidtil ukendt fremgangsmåde til fremstilling af anti-ulcus-midler

Info

Publication number
DK0533264T3
DK0533264T3 DK92202792T DK92202792T DK0533264T3 DK 0533264 T3 DK0533264 T3 DK 0533264T3 DK 92202792 T DK92202792 T DK 92202792T DK 92202792 T DK92202792 T DK 92202792T DK 0533264 T3 DK0533264 T3 DK 0533264T3
Authority
DK
Denmark
Prior art keywords
ulcer agents
preparation
hitherto unknown
unknown method
bridge
Prior art date
Application number
DK92202792T
Other languages
English (en)
Inventor
Ichiro Shinkai
Robert Scott Hoerrner
Joel J Friedman
Joseph Sebastian Amato
Thomas Meng-Han Liu
Leonard M Weinstock
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0533264T3 publication Critical patent/DK0533264T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK92202792T 1991-09-20 1992-09-12 Hidtil ukendt fremgangsmåde til fremstilling af anti-ulcus-midler DK0533264T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76456491A 1991-09-20 1991-09-20
US77787391A 1991-10-15 1991-10-15

Publications (1)

Publication Number Publication Date
DK0533264T3 true DK0533264T3 (da) 2000-05-15

Family

ID=27117485

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92202792T DK0533264T3 (da) 1991-09-20 1992-09-12 Hidtil ukendt fremgangsmåde til fremstilling af anti-ulcus-midler

Country Status (18)

Country Link
US (1) US5391752A (da)
EP (1) EP0533264B1 (da)
JP (1) JPH0720956B2 (da)
KR (1) KR100242622B1 (da)
CN (1) CN1048729C (da)
AT (1) ATE186535T1 (da)
AU (1) AU649355B2 (da)
CA (1) CA2078517C (da)
DE (1) DE69230278T2 (da)
DK (1) DK0533264T3 (da)
ES (1) ES2143468T3 (da)
GR (1) GR3032619T3 (da)
IL (1) IL103156A (da)
MX (1) MX9205333A (da)
NZ (1) NZ244301A (da)
PT (1) PT533264E (da)
WO (1) WO1993006097A1 (da)
YU (1) YU48291B (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
WO1993024480A1 (en) * 1992-06-01 1993-12-09 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and medicinal use thereof
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CN1053444C (zh) * 1996-03-20 2000-06-14 常州市第四制药厂 奥美拉唑的一种精制方法
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SK283805B6 (sk) 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
SE9704183D0 (sv) 1997-11-14 1997-11-14 Astra Ab New process
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
US6191148B1 (en) 1998-08-11 2001-02-20 Merck & Co., Inc. Omerazole process and compositions thereof
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
DE19951960C2 (de) 1999-10-28 2002-06-27 Gruenenthal Gmbh Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
WO2002062786A1 (en) * 2001-02-02 2002-08-15 Teva Pharmaceutical Industries Ltd. Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
KR100783020B1 (ko) * 2001-03-23 2007-12-07 동아제약주식회사 2-메틸클로라이드 피리딘 유도체 및 이를 이용한 벤즈이미다졸 유도체의 제조 방법
IL159854A0 (en) * 2001-07-16 2004-06-20 Janssen Pharmaceutica Nv Improved process for preparing benzimidazole-type compounds
EP1469839A2 (en) * 2002-01-25 2004-10-27 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
WO2004056804A2 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
DE602004020730D1 (de) * 2003-01-15 2009-06-04 Cipla Ltd Pharmazeutisches verfahren und damit hergestellte verbindungen
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1601667A2 (en) * 2003-03-12 2005-12-07 Teva Pharmaceutical Industries Limited Crystalline and amorphous solids of pantoprazole and processes for their preparation
WO2004111029A2 (en) 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005007117A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
AR048631A1 (es) * 2004-04-28 2006-05-10 Altana Pharma Ag Derivados de dialcoxi-imidazopiridinas, composiciones farmaceuticas que los contienen y usos,
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN103772360A (zh) * 2004-06-24 2014-05-07 阿斯利康(瑞典)有限公司 制备用于制备艾美拉唑钠盐的结晶修饰物的新方法
GB0525710D0 (en) * 2005-12-17 2006-01-25 Pliva Hrvatska D O O An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
WO2008017020A2 (en) * 2006-08-03 2008-02-07 Dr. Reddy's Laboratories Limited Process for preparing proton pump inhibitors
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008092939A2 (en) 2007-01-31 2008-08-07 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
WO2013108068A1 (en) 2012-01-21 2013-07-25 Jubilant Life Sciences Limited Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4483781A (en) * 1983-09-02 1984-11-20 The Procter & Gamble Company Magnesium salts of peroxycarboxylic acids
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS61178919A (ja) * 1985-02-04 1986-08-11 Banyu Pharmaceut Co Ltd ベンズイミダゾ−ル誘導体およびそれを含有する医薬
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
FI864046A (fi) * 1986-10-07 1988-04-08 Farmos Oy Foerfarande foer framstaellning av en terapeutiskt aktiv foerening.
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
ZA889194B (en) * 1987-12-11 1989-08-30 Byk Gulden Lomberg Chemisch Fa Novel benzimidazole derivatives
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
SE8804628D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New compounds
FR2660313B1 (fr) * 1990-04-02 1992-07-03 Fournier Ind & Sante Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.

Also Published As

Publication number Publication date
ES2143468T3 (es) 2000-05-16
EP0533264B1 (en) 1999-11-10
KR930006021A (ko) 1993-04-20
AU649355B2 (en) 1994-05-19
CN1048729C (zh) 2000-01-26
JPH05213936A (ja) 1993-08-24
JPH0720956B2 (ja) 1995-03-08
YU89492A (sh) 1995-10-03
US5391752A (en) 1995-02-21
IL103156A0 (en) 1993-02-21
AU2520792A (en) 1993-03-25
DE69230278T2 (de) 2001-04-05
NZ244301A (en) 1994-08-26
CN1071169A (zh) 1993-04-21
PT533264E (pt) 2000-05-31
CA2078517A1 (en) 1993-03-21
CA2078517C (en) 2003-11-04
KR100242622B1 (ko) 2000-03-02
MX9205333A (es) 1993-07-01
IL103156A (en) 1997-02-18
GR3032619T3 (en) 2000-05-31
ATE186535T1 (de) 1999-11-15
WO1993006097A1 (en) 1993-04-01
EP0533264A1 (en) 1993-03-24
DE69230278D1 (de) 1999-12-16
YU48291B (sh) 1998-05-15

Similar Documents

Publication Publication Date Title
DK0533264T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af anti-ulcus-midler
ATE187542T1 (de) Verwendung von halogenkohlenwasserstofflösungsmitteln
DE3580118D1 (de) Herstellung von schmieroelkohlenwasserstoffen aus leichten olefinen.
DE3882055T2 (de) Verfahren zur Herstellung von Pyridin-2,3-dicarboxylsäure-Verbindungen.
DE3866617D1 (de) Verfahren zur herstellung von 2,3-pyridindicarbonsaeure-verbindungen.
DE3853863T2 (de) 4-Aminopyridinderivate.
FI865081A (fi) Nya (2-imidazolin-2-yl) -fusionerade heteropyridinfoereningar, mellanprodukter anvaendbara vid deras framstaellning och deras anvaendning som herbicider.
NO893380D0 (no) Rotator for kranbaarede arbeidsredskaper, saerlig trebearbeidelsesaggregat.
DK157245C (da) Analogifremgangsmaade til fremstilling af e.coli varmestabile enterotoxinderivater
DK160278C (da) Analogifremgangsmaade til fremstilling af dihydropyrazolo(3,4-b)-pyridinderivater
DK408183A (da) Fremgangsmaade til fremstilling af 2-(5,5-disubstitueret 4-oxo-2-imidazolin-2-yl)-nicotinsyrer og quinolin-3-carboxylsyrer
ATE70532T1 (de) Verfahren zur herstellung von oxiden von aromatischen tertiaeren aminen und so erhaltene produkte.
DK427387A (da) Oejenmidler paa basis af alkaloider, 1,3-diphenyl-2-propen-1-on-derivater eller heterocycliske forbindelser
DE68914869D1 (de) Verfahren zur stufenweise Oxydation von substituierten 8-Hydroy-chinolinen zu substituierten Pyridin-2,3-dikarbonsäuren.
DE3771153D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarboxylsaeuren.
KR860005773A (ko) 올레핀류에서 산소함유 유기화합물을 합성하는 방법
NO167457C (no) Fremgangsmaate for fremstilling av 4-acetyl-1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2h)-isokinolinon
ES2026523T3 (es) Metodo para la preparacion de mercaptobenzoatos.
DE68923232D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarbonsäure-verbindungen.
DK483588D0 (da) Diphenyletherderivater
ATE64923T1 (de) Verfahren zur herstellung von pyridin-2,3dicarboxyls|uren.
DE3887144D1 (de) Oxydationsverfahren für Herstellung von aromatischen Säuren aus alkylaromatischen Verbindungen.
TH12774EX (th) อนุพันธ์ต่าง ๆ ของ 4-เบนโซอิลไอซอกซาโซล
IT8320215A0 (it) Procedimento per il recupero di acidi organici inquinati da composti inorganici.